1. Home
  2. VTGN vs AXTI Comparison

VTGN vs AXTI Comparison

Compare VTGN & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTGN
  • AXTI
  • Stock Information
  • Founded
  • VTGN 1998
  • AXTI 1986
  • Country
  • VTGN United States
  • AXTI United States
  • Employees
  • VTGN N/A
  • AXTI N/A
  • Industry
  • VTGN Biotechnology: Pharmaceutical Preparations
  • AXTI Semiconductors
  • Sector
  • VTGN Health Care
  • AXTI Technology
  • Exchange
  • VTGN Nasdaq
  • AXTI Nasdaq
  • Market Cap
  • VTGN 87.2M
  • AXTI 94.4M
  • IPO Year
  • VTGN N/A
  • AXTI 1998
  • Fundamental
  • Price
  • VTGN $3.31
  • AXTI $2.05
  • Analyst Decision
  • VTGN
  • AXTI Strong Buy
  • Analyst Count
  • VTGN 0
  • AXTI 4
  • Target Price
  • VTGN N/A
  • AXTI $4.60
  • AVG Volume (30 Days)
  • VTGN 659.7K
  • AXTI 242.8K
  • Earning Date
  • VTGN 08-07-2025
  • AXTI 07-31-2025
  • Dividend Yield
  • VTGN N/A
  • AXTI N/A
  • EPS Growth
  • VTGN N/A
  • AXTI N/A
  • EPS
  • VTGN N/A
  • AXTI N/A
  • Revenue
  • VTGN $646,000.00
  • AXTI $86,080,000.00
  • Revenue This Year
  • VTGN $23.83
  • AXTI N/A
  • Revenue Next Year
  • VTGN $660.39
  • AXTI $29.07
  • P/E Ratio
  • VTGN N/A
  • AXTI N/A
  • Revenue Growth
  • VTGN N/A
  • AXTI N/A
  • 52 Week Low
  • VTGN $1.90
  • AXTI $1.13
  • 52 Week High
  • VTGN $3.79
  • AXTI $3.07
  • Technical
  • Relative Strength Index (RSI)
  • VTGN 68.10
  • AXTI 44.66
  • Support Level
  • VTGN $2.82
  • AXTI $1.96
  • Resistance Level
  • VTGN $3.05
  • AXTI $2.24
  • Average True Range (ATR)
  • VTGN 0.24
  • AXTI 0.15
  • MACD
  • VTGN 0.01
  • AXTI -0.02
  • Stochastic Oscillator
  • VTGN 93.85
  • AXTI 31.25

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: